Vivanza Biosciences Limited announced earnings results for the full year ended March 31, 2021. For the full year, the company announced total revenue was INR 103.939 million compared to INR 101.913 million a year ago. Net income was INR 0.745 million compared to net loss of INR 2.057 million a year ago. Basic earnings per share from continuing operations was INR 0.19 compared to basic loss per share from continuing operations of INR 0.51 a year ago.